200 related articles for article (PubMed ID: 29937058)
1. Exploration of diphenylalkyloxadiazoles as novel cardiac myosin activator.
Manickam M; Boggu PR; Pillaiyar T; Sharma N; Jalani HB; Venkateswararao E; Jung SH
Bioorg Med Chem Lett; 2018 Aug; 28(14):2369-2374. PubMed ID: 29937058
[TBL] [Abstract][Full Text] [Related]
2. Identification of diphenylalkylisoxazol-5-amine scaffold as novel activator of cardiac myosin.
Boggu PR; Venkateswararao E; Manickam M; Sharma N; Kang JS; Jung SH
Bioorg Med Chem; 2020 Nov; 28(22):115742. PubMed ID: 33007555
[TBL] [Abstract][Full Text] [Related]
3. Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors.
Koryakova AG; Ivanenkov YA; Ryzhova EA; Bulanova EA; Karapetian RN; Mikitas OV; Katrukha EA; Kazey VI; Okun I; Kravchenko DV; Lavrovsky YV; Korzinov OM; Ivachtchenko AV
Bioorg Med Chem Lett; 2008 Jun; 18(12):3661-6. PubMed ID: 18502121
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the structure-activity relationship of 1,2,4-oxadiazole antibiotics.
Ding D; Boudreau MA; Leemans E; Spink E; Yamaguchi T; Testero SA; O'Daniel PI; Lastochkin E; Chang M; Mobashery S
Bioorg Med Chem Lett; 2015 Nov; 25(21):4854-4857. PubMed ID: 26144346
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity.
Pidugu VR; Yarla NS; Pedada SR; Kalle AM; Satya AK
Bioorg Med Chem; 2016 Nov; 24(21):5611-5617. PubMed ID: 27665180
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of sulfonamidophenylethylureas as novel cardiac myosin activator.
Manickam M; Jalani HB; Pillaiyar T; Boggu PR; Sharma N; Venkateswararao E; Lee YJ; Jeon ES; Son MJ; Woo SH; Jung SH
Eur J Med Chem; 2018 Jan; 143():1869-1887. PubMed ID: 29224951
[TBL] [Abstract][Full Text] [Related]
8. Oxadiazole-substituted naphtho[2,3-b]thiophene-4,9-diones as potent inhibitors of keratinocyte hyperproliferation. Structure-activity relationships of the tricyclic quinone skeleton and the oxadiazole substituent.
Basoglu A; Dirkmann S; Zahedi Golpayegani N; Vortherms S; Tentrop J; Nowottnik D; Prinz H; Fröhlich R; Müller K
Eur J Med Chem; 2017 Jul; 134():119-132. PubMed ID: 28410493
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and antibacterial activity of 3-(5-substituted phenyl-[1,3,4] oxadiazole-2-yl-methylenethio)-5-pyridin-3-yl-[1,2,4] triazole-4-yl-amines].
Hu GQ; Xie SQ; Xu QJ; Huang WL; Zhang HB; Huang ST
Yao Xue Xue Bao; 2005 Apr; 40(4):337-9. PubMed ID: 16011262
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular docking study and in vitro thymidine phosphorylase inhibitory potential of oxadiazole derivatives.
Ullah H; Rahim F; Taha M; Uddin I; Wadood A; Shah SAA; Farooq RK; Nawaz M; Wahab Z; Khan KM
Bioorg Chem; 2018 Aug; 78():58-67. PubMed ID: 29533215
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antihepatotoxic activity of 2-(substituted-phenyl)-5-(2,3-dihydro-1,4-benzodioxane-2-yl)-1,3,4-oxadiazole derivatives.
Ahmed B; Habibullah ; Khan S
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):216-21. PubMed ID: 20593971
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as potential hypoxic cytotoxins and DNA-binders.
Cerecetto H; González M; Risso M; Seoane G; López de Ceráin A; Ezpeleta O; Monge A; Suescun L; Mombrú A; Bruno AM
Arch Pharm (Weinheim); 2000 Nov; 333(11):387-93. PubMed ID: 11129981
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles.
Kumar D; Patel G; Johnson EO; Shah K
Bioorg Med Chem Lett; 2009 May; 19(10):2739-41. PubMed ID: 19376704
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4-oxadiazoles as benzodiazepine receptor agonists.
Zarghi A; Faizi M; Shafaghi B; Ahadian A; Khojastehpoor HR; Zanganeh V; Tabatabai SA; Shafiee A
Bioorg Med Chem Lett; 2005 Jun; 15(12):3126-9. PubMed ID: 15876530
[TBL] [Abstract][Full Text] [Related]
15. New Potential Biologically Active Compounds: Synthesis and Characterization of Urea and Thiourea Derivativpes Bearing 1,2,4-oxadiazole Ring.
Ölmez NA; Waseer F
Curr Org Synth; 2020; 17(7):525-534. PubMed ID: 32303172
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents.
Bajaj S; Roy PP; Singh J
Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents.
Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK
Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958
[TBL] [Abstract][Full Text] [Related]
18. 1,3,4-oxadiazole: a privileged structure in antiviral agents.
Li Z; Zhan P; Liu X
Mini Rev Med Chem; 2011 Nov; 11(13):1130-42. PubMed ID: 22353222
[TBL] [Abstract][Full Text] [Related]
19. Exploration of flexible phenylpropylurea scaffold as novel cardiac myosin activators for the treatment of systolic heart failure.
Manickam M; Jalani HB; Pillaiyar T; Sharma N; Boggu PR; Venkateswararao E; Lee YJ; Jeon ES; Jung SH
Eur J Med Chem; 2017 Jul; 134():379-391. PubMed ID: 28432943
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound- and Molecular Sieves-Assisted Synthesis, Molecular Docking and Antifungal Evaluation of 5-(4-(Benzyloxy)-substituted phenyl)-3-((phenylamino)methyl)-1,3,4-oxadiazole-2(3H)-thiones.
Nimbalkar UD; Tupe SG; Seijas Vazquez JA; Khan FA; Sangshetti JN; Nikalje AP
Molecules; 2016 May; 21(5):. PubMed ID: 27171073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
